Ousia - great post. Well thought out.
PI-88 Trials in Taiwan are a much more 'straightforward' proposition then the Multi Country Phase III undertaking.
Recruitment rates are very difficult to predict in terms of such global Trial. Liver Cancer is a much more prevalent disease in Asia as I understand matters, and therefore recruitment rates are more certain there.
A new dawn for Progen!
Ousia - great post. Well thought out.PI-88 Trials in Taiwan are...
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.28M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 44.5¢ | 44.5¢ | $12.04K | 27.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 250821 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 440548 | 13 |
View Market Depth
| Last trade - 13.46pm 19/07/2024 (20 minute delay) ? |
| PGL (ASX) Chart |